1. Research progress on the drug action and resistance mechanism in Mycobacterium tuberculosis.
- Author
-
GE Sai, SONG Xin-yi, JIANG Hui-yue, LI Zhao-yang, ZHU Zhuang-yan, and SUN Man-luan
- Subjects
MYCOBACTERIUM tuberculosis ,DRUG resistance ,ANTITUBERCULAR agents ,DRUG development ,COMMUNICABLE diseases - Abstract
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium Tuberculosis (MTB). It is the second largest single cause of death besides novel coronavirus pneumonia. Along with the abuse of antibiotics and extensive use of anti-tuberculosis drugs, multidrug-resistant (MDR) TB, drug-resistant (XDR) TB and totally drug-resistant (TDR) TB became obstacles to the tuberculosis eradication worldwide. According to the World Health Organization (WHO) statistics, China is not only a high burden tuberculosis country in the world, but also a country with a serious epidemic of MDR. Traditional drugs fail to meet the needs of tuberculosis control. Therefore, it is urgent to find new targets of anti-tuberculosis drugs and develop new anti-tuberculosis drugs. Hence, this paper systematically summarizes the mechanism of traditional and newly developed anti-tuberculosis drugs, in which stressing the research progress of drug resistance mechanisms. This work provides us with new insights of new antituberculosis drug developments, and may contribute to a reduction in the harm that tuberculosis brings to society. [ABSTRACT FROM AUTHOR]
- Published
- 2023